Literature DB >> 1851364

Immunocytochemical and ultrastructural studies of Werdnig-Hoffmann disease.

S Murayama1, T W Bouldin, K Suzuki.   

Abstract

Neuronal alterations in two cases of Werdnig-Hoffmann disease (WH) were investigated immunocytochemically and ultrastructurally. Ballooned neurons (BNs) were found in anterior horn, Clarke's column, dorsal root ganglion and thalamus. Anti-phosphorylated neurofilament antibodies preferentially stained the peripheral perikarya and proximal neuronal processes of BNs, whereas anti-ubiquitin antibodies preferentially stained the central perikarya of BNs. Ultrastructurally, BNs showed degenerative changes ranging from a diffuse increase of neurofilaments to a centrally accentuated accumulation of mitochondria and vesicular or membranous profiles. Our studies suggest that ubiquitinated degradation products accumulate in the center of the BN's perikaryon and displace aberrantly phosphorylated neurofilaments to the periphery. BNs in WH probably reflect an intrinsic alteration in the metabolism of neurofilaments that is associated with regressive changes in the neuron and eventually neuronal death.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851364     DOI: 10.1007/bf00293462

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells.

Authors:  G Sobue; Y Hashizume; T Yasuda; E Mukai; T Kumagai; T Mitsuma; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates.

Authors:  A L Haas; P M Bright
Journal:  J Biol Chem       Date:  1985-10-15       Impact factor: 5.157

3.  Neurofilamentous abnormalities in motor neurons in spontaneously occurring animal disorders.

Authors:  L C Cork; J C Troncoso; G G Klavano; E S Johnson; L A Sternberger; N H Sternberger; D L Price
Journal:  J Neuropathol Exp Neurol       Date:  1988-07       Impact factor: 3.685

4.  Immunocytochemical and ultrastructural study of Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis.

Authors:  S Murayama; Y Ookawa; H Mori; I Nakano; Y Ihara; S Kuzuhara; M Tomonaga
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Swollen cortical neurons in Creutzfeldt-Jakob disease contain a phosphorylated neurofilament epitope.

Authors:  Y Nakazato; J Hirato; Y Ishida; S Hoshi; M Hasegawa; T Fukuda
Journal:  J Neuropathol Exp Neurol       Date:  1990-05       Impact factor: 3.685

6.  Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis.

Authors:  S Murayama; H Mori; Y Ihara; T W Bouldin; K Suzuki; M Tomonaga
Journal:  Ann Neurol       Date:  1990-02       Impact factor: 10.422

7.  Is Werdnig-Hoffmann disease a pure lower motor neuron disorder?

Authors:  J Towfighi; R S Young; R M Ward
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Chromatolytic neurons in Werdnig-Hoffmann disease contain phosphorylated neurofilaments.

Authors:  C F Lippa; T W Smith
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes.

Authors:  D W Dickson; S H Yen; K I Suzuki; P Davies; J H Garcia; A Hirano
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  The response of ventral horn neurons to axonal transection.

Authors:  D L Price; K R Porter
Journal:  J Cell Biol       Date:  1972-04       Impact factor: 10.539

View more
  8 in total

1.  Failure of lower motor neuron radial outgrowth precedes retrograde degeneration in a feline model of spinal muscular atrophy.

Authors:  Erin N Wakeling; Béatrice Joussemet; Patrick Costiou; Dominique Fanuel; Philippe Moullier; Martine Barkats; John C Fyfe
Journal:  J Comp Neurol       Date:  2012-06-01       Impact factor: 3.215

2.  Alpha-synuclein loss in spinal muscular atrophy.

Authors:  Gyula Acsadi; Xingli Li; Kelley J Murphy; Kathryn J Swoboda; Graham C Parker
Journal:  J Mol Neurosci       Date:  2010-07-17       Impact factor: 3.444

3.  Proteomic profile of embryonic stem cells with low survival motor neuron protein is consistent with developmental dysfunction.

Authors:  Graham C Parker; Nicholas J Carruthers; Theresa Gratsch; Joseph A Caruso; Paul M Stemmer
Journal:  J Neural Transm (Vienna)       Date:  2016-05-05       Impact factor: 3.575

4.  Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice.

Authors:  P H Tu; K A Robinson; F de Snoo; J Eyer; A Peterson; V M Lee; J Q Trojanowski
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

5.  Spectrum of neuropathophysiology in spinal muscular atrophy type I.

Authors:  Brian N Harding; Shingo Kariya; Umrao R Monani; Wendy K Chung; Maryjane Benton; Sabrina W Yum; Gihan Tennekoon; Richard S Finkel
Journal:  J Neuropathol Exp Neurol       Date:  2015-01       Impact factor: 3.685

Review 6.  Spinal muscular atrophy: journeying from bench to bedside.

Authors:  Tomoyuki Awano; Jeong-Ki Kim; Umrao R Monani
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

7.  Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy.

Authors:  Graham C Parker; Xingli Li; Roumen A Anguelov; Gabor Toth; Adam Cristescu; Gyula Acsadi
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

8.  UBA1/GARS-dependent pathways drive sensory-motor connectivity defects in spinal muscular atrophy.

Authors:  Hannah K Shorrock; Dinja van der Hoorn; Penelope J Boyd; Maica Llavero Hurtado; Douglas J Lamont; Brunhilde Wirth; James N Sleigh; Giampietro Schiavo; Thomas M Wishart; Ewout J N Groen; Thomas H Gillingwater
Journal:  Brain       Date:  2018-10-01       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.